Drugs / liposomal vincristine sulfate
Trials 3
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01026220 | Dec 2009 → Mar 2012 | nodular lymphocyte predominant Hodgkin lymphoma | Children's Oncology Group | Completed | No outcome recorded |
| Phase 3 | NCT00072384 | Apr 2007 → Feb 2013 | intraocular retinoblastoma | Children's Oncology Group | Completed | No outcome recorded |
| Phase 3 | NCT00335738 | Dec 2005 → Sep 2011 | intraocular retinoblastoma | Children's Oncology Group | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | liposomal vincristine sulfate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00072384 ↗ |
| Route | Intravenous | “Given IV” NCT00072384 ↗ |